Expression of Cytochrome P450 3A4 and Its Clinical Significance in Human Prostate Cancer - 06/08/11
, Satoru Takahashi b, Tomohiko Urano c, Jinpei Kumagai a, Taro Murata a, Kenichi Takayama c, Tetsuo Ogushi a, Kuniko Horie-Inoue d, Yasuyoshi Ouchi c, Tadaichi Kitamura a, Masami Muramatsu d, Yukio Homma a, Satoshi Inoue c, d
Reprint requests: Tetsuya Fujimura, M.D., Ph.D., Department of Urology, Tokyo University Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 JapanRésumé |
Objectives |
To evaluate CYP3A4 expression in human prostrate cancer (PCa) tissues. Enzymes of the cytochrome P450 (CYP) family are key inactivators of testosterone in the liver and prostate. We previously reported that CYP2B6 is a growth-inhibitory and prognostic factor in human PCa; however, the status of CYP3A4 in PCa remains unclear.
Methods |
We used immunohistochemistry to analyze CYP3A4 expression in 107 human PCa specimens obtained by radical prostatectomy. Stained slides were evaluated for the proportion and staining intensity of positively stained cells. Total immunoreactivity scores (0-8) were obtained as the sum of the proportion and intensity scores. In addition, we estimated the relationship between CYP3A4 status and clinicopathologic features.
Results |
CYP3A4 immunoreactivity was identified in the cytoplasm of prostate cells. The CYP3A4 immunoreactive PCa score (3.6±2.6) was significantly lower than that of benign epithelium (4.5±2.1; P < .0001). In addition, CYP3A4 immunoreactivity correlated inversely with the Gleason score (P < .0001). Decreased CYP3A4 immunoreactivity was significantly related to a poor prognosis in human PCa (P = .0175).
Conclusions |
We demonstrated differential CYP3A4 expression in prostatic tissues, indicating that decreased CYP3A4 expression may contribute to the development of PCa.
Le texte complet de cet article est disponible en PDF.Plan
Vol 74 - N° 2
P. 391-397 - août 2009 Retour au numéro
Article précédent
- Prediction of Prostatic Involvement by Urothelial Carcinoma in Radical Cystoprostatectomy for Bladder Cancer
- Roberta Mazzucchelli, Francesca Barbisan, Alfredo Santinelli, Marina Scarpelli, Andrea B. Galosi, Antonio Lopez-Beltran, Liang Cheng, Ziya Kirkali, Rodolfo Montironi
- Nerve Quantification and Computerized Planimetry to Evaluate Periprostatic Nerve Distribution—Does Size Matter?
- Roman Ganzer, Andreas Blana, Jens-Uwe Stolzenburg, Robert Rabenalt, Hans-Martin Fritsche, Wolf F. Wieland, Stefan Denzinger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?